Business Analyst class of 2023
21 September 2023We are thrilled to introduce to you our Business Analyst class of 2023. Let`s welcome Jawad Barbar, Campbell Foubister, Zeynep…Candesic`s Dr Joe Taylor and Dr Leonid Shapiro published in the latest PharmaTimes
20 September 2023Candesic`s Dr Joe Taylor and Dr Leonid Shapiro discuss in PharmaTimes the significant opportunities, and the challenges, in the use…Dr Leonid Shapiro shared his expertise in the latest Healthcare Business International
18 September 2023Candesic Managing Partner Dr Leonid Shapiro shared his expertise in the latest Healthcare Business International. Dr Leonid Shapiro discusses the challenges…Dr Michelle Tempest driving the brain capital initiative
15 September 2023We are thrilled to announce Candesic Senior Partner Dr Michelle Tempest, continues to drive the exciting brain capital initiative with…
Obesity treatment and the rise of the GLP-1 agonist
17 August 2023Candesic partner Dr Michelle Tempest and Dr Bharadwaj Chada feature on the new HealthcareMarkets UK issue. Our team investigates the…What could more private equity involvement mean for the future of healthcare in the UK?
15 August 2023In a new Financial Times article, Candesic Senior Partner Dr Michelle Tempest provides insight into NHS's interactions with private healthcare…75 years on: is the future of the NHS private?
19 July 2023Managing Partner at Candesic, Dr Leonid Shapiro featured in the new article by Healthcare Business International. Dr Leonid Shapiro discusses the rising demand for private…
EAP on the rise- what took so long?
18 July 2023Marc Kitten, Senior Partner at Candesic shares his expertise on Employee Assistance Programmes (EAP) which over the years have evolved…Private equity bets on NHS backlog with recruitment agency deal
10 July 2023Dr Michelle Tempest, Senior Partner at Candesic commented in the Financial Times on insourcing and the latest sector investment in…Where to look for green shoots in health care M&A
22 June 2023Candesic Senior Partners Marc Kitten and Dr Michelle Tempest comment on current M&A prospects in European healthcare in the latest…
